Perception of Affordances and Obstacle Crossing in People With Parkinson's Disease and Healthy Adults
NCT ID: NCT06932679
Last Updated: 2025-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
180 participants
OBSERVATIONAL
2025-04-24
2028-06-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer-based Cognitive Training for Parkinson Disease
NCT01121627
Self-motion Perception in Parkinson's Disease
NCT03137238
Visual Function During Gait in Parkinson's Disease: Impact of Cognition and Response to Visual Cues
NCT02610634
Attending to External Cues and Movement Strategies in Parkinson Disease
NCT04674319
The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson“s Disease (PD)
NCT01391741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will include 60 PwP and 120 healthy adults (60 older adults and 60 young adults). All participants will perform walking tasks involving obstacle crossing under different environmental conditions (e.g., different obstacle heights and surfaces). Prior to walking, participants will judge whether they can safely cross the obstacle. Eye-tracking glasses will measure visual exploration patterns to assess how participants scan the environment. Additionally, walking variables such as speed and step length, will be recorded using wearable sensors.
The study will explore:
1. Differences in affordance perception between PwP and healthy adults.
2. Associations between motor and cognitive impairments and affordance perception in PwP.
3. How affordance perception relates to gait performance during obstacle crossing.
Results from this study may help to develop new intervention strategies aimed at improving safe walking and obstacle negotiation in PwP.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's Disease
Participants diagnosed with Parkinson's disease (PwP), aged 60-80 years, able to walk independently outdoors.
Assessment of Gait and Visual Exploration
Participants will perform walking tasks involving obstacle crossing while their gait and visual exploration patterns are recorded using wearable sensors and eye-tracking glasses. This is a non-invasive observational study with no therapeutic intervention.
Healthy Older Adults
Healthy adults aged 60-80 years, without neurological or orthopedic conditions affecting gait.
Assessment of Gait and Visual Exploration
Participants will perform walking tasks involving obstacle crossing while their gait and visual exploration patterns are recorded using wearable sensors and eye-tracking glasses. This is a non-invasive observational study with no therapeutic intervention.
Healthy Young Adults
Healthy adults aged 20-30 years, without neurological or orthopedic conditions affecting gait.
Assessment of Gait and Visual Exploration
Participants will perform walking tasks involving obstacle crossing while their gait and visual exploration patterns are recorded using wearable sensors and eye-tracking glasses. This is a non-invasive observational study with no therapeutic intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of Gait and Visual Exploration
Participants will perform walking tasks involving obstacle crossing while their gait and visual exploration patterns are recorded using wearable sensors and eye-tracking glasses. This is a non-invasive observational study with no therapeutic intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to walk independently outdoors without assistive devices.
* For Parkinson's Disease (PD) group: Diagnosis of PD confirmed by medical records.
* For healthy control groups: No neurological or orthopedic conditions affecting gait.
Exclusion Criteria
* Severe visual impairment that cannot be corrected with glasses or lenses.
* Cognitive impairment, defined as a score below 18 on the telephone-based Mini-Mental State Examination (MMSE).
* Any orthopedic condition, pain, or other medical condition that may affect walking, based on self-report.
20 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Haifa, Israel
UNKNOWN
University of Haifa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Galit Yogev-Seligmann
Senior Lecturer, Department of Occupational Therapy, Faculty of Social Welfare and Health Sciences, University of Haifa
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Galit Yogev Seligmann, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Haifa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Haifa, Motor Performance Laboratory
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1561/25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.